Articles & Research from Venn Life Sciences

Pharmacokinetics (PK) and Pharmacodynamics (PD) of a New Direct Thrombin Inhibitor (DPOC-4088) After Single Oral Doses of Two Prolonged Release Formulations in Healthy Male Subjects (NCT01347203)

Interaction of Pipamperone, Citalopram, and Genetic Variables in the Prediction of Antidepressant Response

Phase III Dose Selection for PNB01, a Novel Fixed-Dose Combination Antidepressant Inducing a Faster and Sustained Response

Population PK/PD Modeling of a Hepatitis C NS3 Inhibitor

Evaluating Dosing Regimens of a Hepatitis C NS3 Inhibitor using PK/PD Modeling

Validation of an in Vivo Phenotyping Cocktail for the Early Detection of Inductive or Inhibitory Potential of New Drugs

A preliminary population pharmacokinetic model for dose selection of treosulfan used in conditioning treatment prior to haematopoietic stem cell transplantation (HSCT) in children

Once-Daily Regimens of the HCV NS3/4A-Protease Inhibitor TMC435350 are predicted to provide Therapeutic Exposure in Plasma and Liver

1 2 3 … 7 Next »